SERUM TRANSAMINASE LEVELS IN LIVER DISEASE

Serum transaminase levels in liver disease.

The process of transamination takes place in many tissues in the body and is a fundamental mechanism in the metabolism of amino-acids. Basically it consists of the reversible transfer of an amino group from an amino-acid to a keto acid, providing a link between protein and carbohydrate metabolism. Although there appear to be a multitude of transamination systems, each catalysed by a specific en...

Serum transaminase levels in experimental myocardial infarction.

Serum glutamic oxalacetic transaminase concentrations rise sharply after myocardial infarction prodlucedl by bead embolization of the coronary tree in the closed chest dclog. The peak concentration is reached in 9 to 23 hours post injury. Rises 20 to 30 times greater than normal may be obtained and are directly correlated with the amount of infarction estimated at autopsy. Serial serum transami...

Transaminase activities of liver tumors and serum.

The glutamic oxalacetic transaminase (GOT) activities of five transplanted malignant liver tumors were compared, as well as that of mammary adenocarcinoma 6338, the Walker carcinosarcoma ~56, and the livers and sera of the host rats. Bile and urine were analyzed in some additional experiments with Hepatoma 51~3. The GOT activity of Hepatoma 51~3, unlike that of the Dunning, the Novikoff, the Mo...

Serum leptin levels in psoriatic patients with non-alcoholic fatty liver disease

Background: The prevalence of non-alcoholic fatty liver disease is higher in patients with psoriasis than in the normal population. Serum leptin levels are higher in patients with psoriasis and in patients with non-alcoholic fatty liver. The purpose of this study was to determine the serum levels of leptin in psoriatic patients with and without non-alcoholic fatty liver.<span...

Serum transaminase activity in leprosy in relation to liver damage.